A Real‐World Study of <scp>CGRP</scp> Monoclonal Antibodies for Migraine: Long‐Term Effectiveness and Treatment AdherenceKeisuke Suzuki, K. Hirata, S. Kobayashi et al.|European Journal of Neurology|2026Cited by 3